INM INMED PHARMACEUTICALS INC Product Launches 8-K Filing 2024 - Regulation FD Disclosure Inmed Pharmaceuticals announced positive preclinical data for potential Alzheimer's disease treatment.Get access to all SEC 8-K filings of the INMED PHARMACEUTICALS INC